{"id":"https://openalex.org/W2183586611","doi":null,"title":"L'\u00e9TUDE CLINIQUE DU MOIS CONTr\u00f4LE gL yC\u00e9MIQUE ET MOrbI- MOrTaLIT\u00e9 CarDIO-vaSCULaIrE ChEz LE paTIENT DIab\u00e9TIQUE DE TypE 2 r\u00e9sultats des \u00e9tudes aCCOrD, aDvaNCE et va-Diabetes","display_name":"L'\u00e9TUDE CLINIQUE DU MOIS CONTr\u00f4LE gL yC\u00e9MIQUE ET MOrbI- MOrTaLIT\u00e9 CarDIO-vaSCULaIrE ChEz LE paTIENT DIab\u00e9TIQUE DE TypE 2 r\u00e9sultats des \u00e9tudes aCCOrD, aDvaNCE et va-Diabetes","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2183586611","mag":"2183586611"},"language":"fr","primary_location":{"id":"mag:2183586611","doi":null,"is_oa":false,"landing_page_url":"http://orbi.ulg.ac.be/bitstream/2268/4215/1/20080708_12.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061794933","display_name":"Chef de Clinique","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Chef de Clinique","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5061794933"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9667999744415283,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/intensive-glycemic-control","display_name":"tight glycemic control","score":0.7720000147819519},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.906000018119812},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.6380000114440918},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.7559999823570251},{"id":"https://openalex.org/keywords/accord-trial","display_name":"ACCORD trial","score":0.7979999780654907},{"id":"https://openalex.org/keywords/advance-trial","display_name":"ADVANCE trial","score":1.0},{"id":"https://openalex.org/keywords/gliclazide","display_name":"gliclazide","score":0.8140000104904175},{"id":"https://openalex.org/keywords/diabetic-nephropathy","display_name":"diabetic nephropathy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.925000011920929},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.8769999742507935},{"id":"https://openalex.org/keywords/cerebrovascular-disease","display_name":"cerebrovascular disease","score":0.8840000033378601},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.92780601978302},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5656298398971558},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5519223213195801},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5242493748664856},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5066136121749878},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45053598284721375},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1833767294883728},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2183586611","doi":null,"is_oa":false,"landing_page_url":"http://orbi.ulg.ac.be/bitstream/2268/4215/1/20080708_12.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W47908862","https://openalex.org/W84368201","https://openalex.org/W131862834","https://openalex.org/W165619514","https://openalex.org/W169318418","https://openalex.org/W1526927233","https://openalex.org/W1752045965","https://openalex.org/W1977952802","https://openalex.org/W1980645862","https://openalex.org/W1998727533","https://openalex.org/W2086199335","https://openalex.org/W2102108180","https://openalex.org/W2102312517","https://openalex.org/W2107031719","https://openalex.org/W2110664743","https://openalex.org/W2123946565","https://openalex.org/W2154067841","https://openalex.org/W2159719778","https://openalex.org/W2170271198","https://openalex.org/W2237997861","https://openalex.org/W2245485450","https://openalex.org/W2288270753","https://openalex.org/W2291054581","https://openalex.org/W2337454357","https://openalex.org/W2423086332","https://openalex.org/W2432242886","https://openalex.org/W4234853462"],"related_works":["https://openalex.org/W2416875811","https://openalex.org/W2064931757","https://openalex.org/W1582436340","https://openalex.org/W1984704645","https://openalex.org/W3160940623","https://openalex.org/W2112507264","https://openalex.org/W2187895155","https://openalex.org/W2479541138","https://openalex.org/W2045769051","https://openalex.org/W2606842683"],"abstract_inverted_index":{"pat":[0],"I":[1,4,9,25],"ents":[2],"w":[3],"th":[5],"type":[6,274],"2":[7,30,275,294],"d":[8],"a":[10,20,35,113],"B":[11,21],"etes":[12,22],".":[13],"results":[14,82],"of":[15,38,46,64,74,83,101,106,116,168,183,213,223,230,262],"accord,":[16],"advance":[17],"and":[18,52,148,165,226,280],"va-dI":[19],"t":[23],"r":[24],"als":[26],"SUMMARY":[27],":":[28,292],"Type":[29,293],"diabetes":[31,295],"is":[32,77,283],"associated":[33],"with":[34,136,200,221,236],"high":[36],"risk":[37,73,182,229,246,288],"complications,":[39,185],"essentially":[40],"macrovascular":[41],"events.":[42],"Surprisingly,":[43],"the":[44,61,72,81,96,120,126,130,134,137,146,154,160,163,166,176,181,192,211,224,228,241,244,251,259],"effect":[45,212],"improved":[47],"glucose":[48,215,264],"control":[49,87,216,265],"on":[50,98,217,266],"coronary":[51,279],"cerebrovascular":[53,281],"complications":[54,76,219],"in":[55,119,132,153,159,191,234,250],"this":[56],"population":[57],"remains":[58],"questionable":[59],"Furthermore,":[60],"target":[62,285],"level":[63],"glycated":[65],"haemoglobin":[66],"(HbA":[67,141,195],"1c":[68,142,196,300],")":[69],"to":[70,111,125,257,272,284],"minimise":[71],"diabetic":[75,276],"controversial.":[78],"We":[79],"report":[80],"three":[84,242],"recent":[85],"randomised":[86],"trials":[88],"(ACCORD,":[89],"ADVANCE,":[90],"Veterans":[91],"Affairs":[92],"Diabetes),":[93],"which":[94,254],"assessed":[95],"impact":[97,261],"cardiovascular":[99,117,149,169,218,231,267,287],"events":[100,118,170,232],"intensive":[102,121,155,193,252],"glucose-lowering":[103],"therapy.":[104],"None":[105],"these":[107],"studies":[108],"was":[109,151,188,247],"able":[110],"demonstrate":[112],"significant":[114],"reduction":[115],"group":[122,194],"as":[123,204],"compared":[124],"standard":[127],"group.":[128,156],"On":[129],"contrary,":[131],"ACCORD,":[133],"study":[135],"most":[138],"ambitious":[139],"goal":[140],"<":[143],"6":[144],"%),":[145],"overall":[147],"mortality":[150,164],"greater":[152],"In":[157,240],"contrast,":[158],"ADVANCE":[161],"trial,":[162],"incidence":[167],"were":[171],"not":[172],"statistically":[173],"different":[174],"between":[175],"two":[177],"treatment":[178],"groups,":[179],"whereas":[180],"microangiopathic":[184],"especially":[186],"nephropathy,":[187],"significantly":[189],"decreased":[190],"\u2264":[197],"6.5":[198],"%,":[199],"modified":[201],"release":[202],"gliclazide":[203],"main":[205],"treatment).":[206],"Finally,":[207],"VA-Diabetes":[208],"showed":[209],"that":[210,227],"better":[214,263],"disappeared":[220],"duration":[222],"disease":[225,282,306],"increased":[233,249],"patients":[235,277],"severe":[237],"hypoglycaemic":[238,245],"episodes.":[239],"studies,":[243],"indeed":[248],"group,":[253],"may":[255],"contribute":[256],"reduce":[258],"positive":[260],"complications.":[268],"The":[269],"best":[270],"way":[271],"protect":[273],"against":[278],"all":[286],"factors.":[289],"K":[290],"eywords":[291],"\u2013":[296,301,303],"Gliclazide":[297],"-":[298],"HbA":[299],"Nephropathy":[302],"Coronary":[304],"artery":[305]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}